Ted Kang and Cathy Burgess were featured speakers during this webinar program sponsored by the Washington Legal Foundation (WLF). With increased outsourcing of medical product production, federal regulators and prosecutors have signaled a renewed focus on current good manufacturing practice (cGMP) compliance. One recent criminal and civil settlement tying cGMP violations to the False Claims Act is powerfully reflective of this resolve. This program examined this and similar federal actions and offer ways that companies can minimize the risk of FDA or DOJ enforcement.
June 13, 2013
10:00 a.m. - 11:00 a.m.